New program aims to ease mental and physical side effects of immunotherapy

NCT ID NCT05715255

First seen May 30, 2026 · Last updated Jun 11, 2026 · Updated 5 times

Summary

This study tests a program that helps cancer survivors on immune checkpoint inhibitors better manage their symptoms and reduce psychological distress. About 400 adults with breast, colon, lung, skin, or rectal cancer who recently started immunotherapy will receive weekly symptom tracking and self-management support. The goal is to see if this approach lowers anxiety, depression, and other side effects, and helps avoid treatment delays.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Arizona Cancer Center

    RECRUITING

    Tucson, Arizona, 85724, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

  • University of Michigan

    ACTIVE_NOT_RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Valleywise Health Medical Center

    ACTIVE_NOT_RECRUITING

    Phoenix, Arizona, 85008, United States

Conditions

Explore the condition pages connected to this study.